{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:54:12Z","timestamp":1761486852465},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[1999,2,26]],"date-time":"1999-02-26T00:00:00Z","timestamp":919987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1038\/sj.bjc.6690242","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:04:07Z","timestamp":1032271447000},"page":"1519-1521","source":"Crossref","is-referenced-by-count":21,"title":["Elevated reticulocyte count \u2013 a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report"],"prefix":"10.1038","volume":"79","author":[{"given":"S","family":"Serke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Riess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Oettle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,2,26]]},"reference":[{"key":"BF6690242_CR1","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1200\/JCO.1994.12.9.1821","volume":"12","author":"H Anderson","year":"1994","unstructured":"Anderson, H., Lund, B., Bach, F., Thatcher, N., Walling, J. & Hansen, H. H. (1994). Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 12: 1821\u20131826.","journal-title":"J Clin Oncol"},{"key":"BF6690242_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2141.1962.tb06541.x","volume":"8","author":"MC Brain","year":"1962","unstructured":"Brain, M. C., Dacie, J. V. & Hourihane, O. B. (1962). Microangiopathic hemolytic anemia: the possible role of vascular lesions in pathogenesis. Br J Haematol 8: 358\u2013364.","journal-title":"Br J Haematol"},{"key":"BF6690242_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/jnci\/89.24.1895","volume":"89","author":"T Brodowicz","year":"1997","unstructured":"Brodowicz, T., Breiteneder, S., Witschke, C. & Zielinski, C. C. (1997). Gemcitabine-induced hemolytic uremic syndrome: a case report (letter). J Natl Cancer Inst 89: 1895\u20131896.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690242_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00873232","volume":"12","author":"ES Casper","year":"1994","unstructured":"Casper, E. S., Green, M. R., Kelsen, D. P., Heelan, R. T., Brown, T. D., Flombaum, C. D., Trochanowski, B. & Tarassoff, P. G. (1994). Phase II trial of gemcitabine (2,2\u2032-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs 12: 29\u201334.","journal-title":"Invest New Drugs"},{"key":"BF6690242_CR5","first-page":"1189","volume":"10","author":"PJ Conlon","year":"1995","unstructured":"Conlon, P. J., Howell, D. N., Macik, G., Kovalik, E. C. & Smith, S. R. (1995). The renal manifestations and outcome of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome in adults. Nephrol Dial Transplant 10: 1189\u20131193.","journal-title":"Nephrol Dial Transplant"},{"key":"BF6690242_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/00001813-199707000-00005","volume":"8","author":"H Cortes-Funes","year":"1997","unstructured":"Cortes-Funes, H., Martin, C., Abratt, R. & Lund, B. (1997). Safety profile of gemcitabine, a novel anticancer agent, in non-small-cell lung cancer. Anticancer Drugs 8: 582\u2013587.","journal-title":"Anticancer Drugs"},{"key":"BF6690242_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/jcp.36.1.24","volume":"36","author":"J Crocker","year":"1983","unstructured":"Crocker, J. & Jones, E. L. (1983). Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma. J Clin Pathol 36: 24","journal-title":"J Clin Pathol"},{"key":"BF6690242_CR8","first-page":"528","volume":"47","author":"M DeWit","year":"1996","unstructured":"DeWit, M., Weh, H. J. & Hossfeld, D. K. (1996). Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Med Welt 47: 528\u2013532.","journal-title":"Med Welt"},{"key":"BF6690242_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1023\/A:1008225930573","volume":"9","author":"M Dobbie","year":"1998","unstructured":"Dobbie, M., Hofer, S., Oberholzer, M. & Herrmann, R. (1998). Veno-occlusive disease of the liver induced by gemcitabine (letter). Ann Oncol 9: 681","journal-title":"Ann Oncol"},{"key":"BF6690242_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s002770050184","volume":"72","author":"M Furlan","year":"1996","unstructured":"Furlan, M. (1996). Von Willebrand factor: molecular size and functional activity. Ann Hematol 72: 341\u2013348.","journal-title":"Ann Hematol"},{"key":"BF6690242_CR11","first-page":"32","volume":"23","author":"MR Green","year":"1996","unstructured":"Green, M. R. (1996). Gemicitabine safety overview. Semin Oncol 23(suppl 10): 32\u201335.","journal-title":"Semin Oncol"},{"key":"BF6690242_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0272-6386(97)90042-1","volume":"29","author":"JA Groff","year":"1997","unstructured":"Groff, J. A., Kozak, M., Boehmer, J. P., Demko, T. M. & Diamond, J. R. (1997). Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy. Am J Kidney Dis 29: 280\u2013284.","journal-title":"Am J Kidney Dis"},{"key":"BF6690242_CR13","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/1097-0142(19800501)45:9<2252::AID-CNCR2820450906>3.0.CO;2-N","volume":"45","author":"SC Gulati","year":"1980","unstructured":"Gulati, S. C., Sordillo, P. & Kempin, S., et al (1980). Microangiopathic hemolytic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil. Cancer 45: 2252","journal-title":"Cancer"},{"key":"BF6690242_CR14","first-page":"603","volume":"106","author":"F Keller","year":"1994","unstructured":"Keller, F., Schwarze, H. & Schwarz, A. (1994). Clinical management of hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura. Wien Klin Wochenschr 106: 603\u2013607.","journal-title":"Wien Klin Wochenschr"},{"key":"BF6690242_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V75.1.116.116","volume":"75","author":"J Kienast","year":"1990","unstructured":"Kienast, J. & Schmitz, G. (1990). Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75: 116\u2013121.","journal-title":"Blood"},{"key":"BF6690242_CR16","first-page":"153","volume":"45","author":"T Matsumae","year":"1996","unstructured":"Matsumae, T., Takebayashi, S. & Naito, S. (1996). The clinico-pathological characteristics and outcome in hemolytic-uremic syndrome of adults. Clin Nephrol 45: 153\u2013162.","journal-title":"Clin Nephrol"},{"key":"BF6690242_CR17","first-page":"1845","volume":"13","author":"B Nordstrom","year":"1993","unstructured":"Nordstrom, B. & Strang, P. (1993). Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review. Anticancer Res 13: 1845\u20131850.","journal-title":"Anticancer Res"},{"key":"BF6690242_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/08860229709026289","volume":"19","author":"YAS Sens","year":"1997","unstructured":"Sens, Y. A. S., Miorin, L. A., Silva, H. G. C., Malheiros, DMAC, Filho, D. M. & Jabur, P. (1997). Acute renal failure due to hemolytic-uremic syndrome in adult patients. Renal Fail 19: 279\u2013282.","journal-title":"Renal Fail"},{"key":"BF6690242_CR19","first-page":"274","volume":"1","author":"M Streiff","year":"1993","unstructured":"Streiff, M. & Bell, W. R. (1993). Thrombotic thrombocytopenic purpura \u2013 hemolytic uremic syndrome. Curr Opin Hematol 1: 274","journal-title":"Curr Opin Hematol"},{"key":"BF6690242_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00001813-199512006-00005","volume":"6","author":"M Tonato","year":"1995","unstructured":"Tonato, M., Mosconi, A. M. & Martin, C. (1995). Safety profile of gemcitabine. Anticancer Drugs 6(suppl 6): 27\u201332.","journal-title":"Anticancer Drugs"},{"key":"BF6690242_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0277-5379(87)90014-9","volume":"23","author":"J Verwey","year":"1987","unstructured":"Verwey, J., De Vries, J. & Pinedo, H. M. (1987). Mitomycin C-induced renal toxicity, a dose-dependent side effect? Eur J Cancer 23: 195","journal-title":"Eur J Cancer"},{"key":"BF6690242_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<213::AID-AJH1>3.0.CO;2-0","volume":"53","author":"ZR Zeigler","year":"1996","unstructured":"Zeigler, Z. R., Rosenfeld, C. S., Andrews, III D. F., Nemunaitis, J., Raymond, J. M., Shadduck, R. K., Kramer, R. E., Gryn, J. F., Rintels, P. B., Besa, E. C. & George, J. N. (1996). Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura\/hemolytic uremic syndromes (TTP\/HUS) and bone marrow transplant-associated microangiopathy (BMT-TM). Am J Hematol 53: 213\u2013220.","journal-title":"Am J Hematol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690242","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:51:31Z","timestamp":1684414291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,26]]},"references-count":22,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["BF6690242"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690242","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2,26]]}}}